NOVARTIS | BLUE PEARL TEXSPIN | NOVARTIS/ BLUE PEARL TEXSPIN |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 29.0 | 5.1 | 565.0% | View Chart |
P/BV | x | 3.4 | - | - | View Chart |
Dividend Yield | % | 2.4 | 0.0 | - |
NOVARTIS BLUE PEARL TEXSPIN |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NOVARTIS Mar-24 |
BLUE PEARL TEXSPIN Mar-24 |
NOVARTIS/ BLUE PEARL TEXSPIN |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,224 | 44 | 2,767.4% | |
Low | Rs | 561 | 31 | 1,786.8% | |
Sales per share (Unadj.) | Rs | 135.7 | 10.2 | 1,336.5% | |
Earnings per share (Unadj.) | Rs | 34.5 | -2.7 | -1,300.1% | |
Cash flow per share (Unadj.) | Rs | 35.6 | -2.7 | -1,340.0% | |
Dividends per share (Unadj.) | Rs | 25.00 | 0 | - | |
Avg Dividend yield | % | 2.8 | 0 | - | |
Book value per share (Unadj.) | Rs | 301.7 | -7.1 | -4,239.7% | |
Shares outstanding (eoy) | m | 24.69 | 0.26 | 9,496.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.6 | 3.7 | 179.5% | |
Avg P/E ratio | x | 25.9 | -14.1 | -183.1% | |
P/CF ratio (eoy) | x | 25.1 | -14.1 | -177.6% | |
Price / Book Value ratio | x | 3.0 | -5.2 | -56.5% | |
Dividend payout | % | 72.5 | 0 | - | |
Avg Mkt Cap | Rs m | 22,037 | 10 | 227,656.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 230 | 0 | 88,307.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,351 | 3 | 126,920.5% | |
Other income | Rs m | 617 | 0 | - | |
Total revenues | Rs m | 3,968 | 3 | 150,284.1% | |
Gross profit | Rs m | 653 | -1 | -94,579.7% | |
Depreciation | Rs m | 26 | 0 | - | |
Interest | Rs m | 15 | 0 | - | |
Profit before tax | Rs m | 1,228 | -1 | -178,029.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 377 | 0 | - | |
Profit after tax | Rs m | 852 | -1 | -123,463.8% | |
Gross profit margin | % | 19.5 | -26.0 | -75.0% | |
Effective tax rate | % | 30.6 | 0 | - | |
Net profit margin | % | 25.4 | -26.0 | -97.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,419 | 5 | 201,258.5% | |
Current liabilities | Rs m | 3,998 | 7 | 59,146.4% | |
Net working cap to sales | % | 161.8 | -78.7 | -205.5% | |
Current ratio | x | 2.4 | 0.7 | 340.3% | |
Inventory Days | Days | 994 | 29 | 3,405.5% | |
Debtors Days | Days | 45 | 1,082,459 | 0.0% | |
Net fixed assets | Rs m | 9,190 | 0 | 3,995,695.7% | |
Share capital | Rs m | 123 | 3 | 4,820.3% | |
"Free" reserves | Rs m | 7,325 | -4 | -166,095.2% | |
Net worth | Rs m | 7,448 | -2 | -402,605.4% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 18,609 | 5 | 379,002.0% | |
Interest coverage | x | 83.4 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.2 | 0.5 | 33.5% | |
Return on assets | % | 4.7 | -14.0 | -33.4% | |
Return on equity | % | 11.4 | 37.1 | 30.9% | |
Return on capital | % | 16.7 | 37.0 | 45.1% | |
Exports to sales | % | 0.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 24 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 24 | 0 | - | |
Fx outflow | Rs m | 825 | 0 | - | |
Net fx | Rs m | -801 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,134 | 2 | 56,417.9% | |
From Investments | Rs m | 331 | NA | - | |
From Financial Activity | Rs m | -1,210 | 1 | -120,990.0% | |
Net Cashflow | Rs m | 255 | 3 | 8,485.0% |
Indian Promoters | % | 0.0 | 0.1 | - | |
Foreign collaborators | % | 70.7 | 19.5 | 361.7% | |
Indian inst/Mut Fund | % | 0.7 | 0.0 | 3,550.0% | |
FIIs | % | 0.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.3 | 80.3 | 36.5% | |
Shareholders | 39,596 | 8,390 | 471.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare NOVARTIS With: ADANI ENTERPRISES MMTC REDINGTON SIRCA PAINTS INDIA SAT INDUSTRIES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Novartis | E-WHA FOAM (I) | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.14% | 0.00% | 1.23% |
1-Month | -1.38% | 22.60% | -0.24% |
1-Year | 47.84% | 258.03% | 43.62% |
3-Year CAGR | 10.82% | 100.60% | 20.35% |
5-Year CAGR | 8.88% | 59.64% | 26.24% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the E-WHA FOAM (I) share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of E-WHA FOAM (I) the stake stands at 19.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of E-WHA FOAM (I).
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 25.0 per share. This amounted to a Dividend Payout ratio of 72.5%.
E-WHA FOAM (I) paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Novartis, and the dividend history of E-WHA FOAM (I).
For a sector overview, read our pharmaceuticals sector report.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.